4.5 Article

The spectrum of benign myoclonus of early infancy: Clinical and neurophysiologic features in 102 patients

期刊

EPILEPSIA
卷 50, 期 5, 页码 1176-1183

出版社

WILEY-BLACKWELL PUBLISHING, INC
DOI: 10.1111/j.1528-1167.2008.01994.x

关键词

Benign nonepileptic; Paroxysmal abnormal movements; Infants; Myoclonus; Spasms; Shuddering

向作者/读者索取更多资源

To redefine benign myoclonus of early infancy (BMEI) through analysis of clinical and neurophysiologic features in 102 patients with the aim to widen the spectrum of the syndrome, including a number of different clinical expressions of transient nonepileptic paroxysmal movements occurring in normal infants. We recruited patients from one center in Argentina and two in Italy, including infants with normal neurologic and psychomotor development presenting with brief paroxysmal abnormal movements. Children with motor phenomena occurring only during sleep were excluded. Patients with abnormal interictal or ictal electroencephalography (EEG) findings were also excluded. The follow-up ranged from 2-40 years. One hundred and two infants (60 male) met the inclusion criteria. Age at onset ranged from 1-12 months, with a median age of 6.2 months. The following nonepileptic paroxysmal motor phenomena were recognized: (1) myoclonus, (2) spasms and brief tonic contractions, (3) shuddering, (4) atonia or negative myoclonus, (5) more than one type of motor phenomenon. In the majority of cases the episodes occurred only while awake and repeated several times a day. In 45 (44.1%) of the 102 cases contractions appeared in clusters. Based on the analysis of clinical and EMG features in this large series of infants, we postulate that the spectrum of the syndrome is wider than initially suspected, and that the different transient motor manifestations and their correlation with different EMG patterns will allow recognition of this definitely benign condition comprising a variety of episodic motor phenomena in normal babies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Dominantly acting KIF5B variants with pleiotropic cellular consequences cause variable clinical phenotypes

Elisabetta Flex, Shahad Albadri, Francesca Clementina Radio, Serena Cecchetti, Antonella Lauri, Manuela Priolo, Marta Kissopoulos, Giovanna Carpentieri, Giulia Fasano, Martina Venditti, Valentina Magliocca, Emanuele Bellacchio, Carrie L. Welch, Paolo C. Colombo, Stephanie M. Kochav, Richard Chang, Rebekah Barrick, Marina Trivisano, Alessia Micalizzi, Rossella Borghi, Elena Messina, Cecilia Mancini, Simone Pizzi, Flavia De Santis, Marion Rosello, Nicola Specchio, Claudia Compagnucci, Kirsty McWalter, Wendy K. Chung, Filippo Del Bene, Marco Tartaglia

Summary: Kinesins are motor proteins involved in intracellular transport, contributing to key cellular processes. Pathogenic variants in kinesin-encoding genes underlie human diseases. Understanding the significance of these variants is important for better understanding the cellular transport system and its relationship with diseases.

HUMAN MOLECULAR GENETICS (2023)

Article Clinical Neurology

Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication

Sara Matricardi, Sandrine Cestele, Marina Trivisano, Benedetta Kassabian, Nathalie Leroudier, Roberta Vittorini, Margherita Nosadini, Elisabetta Cesaroni, Sabrina Siliquini, Cristina Marinaccio, Francesca Longaretti, Barbara Podesta, Francesca Felicia Operto, Concetta Luisi, Stefano Sartori, Clementina Boniver, Nicola Specchio, Federico Vigevano, Carla Marini, Massimo Mantegazza

Summary: This study aimed to refine the spectrum of SCN1A epileptic disorders beyond DS and GEFS+ and optimize antiseizure management. Nine of the 16 probands had de novo pathogenic variants causing DEE, while seven probands manifested focal epilepsies with mild or no intellectual disability. Sodium channel blockers never worsened seizures, and functional analysis showed a gain of channel function for three representative variants. The study highlights the wide range of SCN1A disorders and the importance of SCN1A testing in pediatric, familial and nonfamilial, focal epilepsies.

EPILEPSIA (2023)

Article Behavioral Sciences

Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment

Kim I. Bishop, Peter K. Isquith, Gerard A. Gioia, Kelly G. Knupp, Ingrid E. Scheffer, Rima Nabbout, Nicola Specchio, Joseph Sullivan, Stephane Auvin, J. Helen Cross, Renzo Guerrini, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni

Summary: This study aimed to evaluate the association between fenfluramine (FFA) and improvement in everyday executive function (EF) in preschool-aged children with Dravet syndrome (DS). The results showed that the FFA treatment group demonstrated reliable and clinically meaningful improvement in self-control, flexibility, metacognition, and overall executive function. Among the FFA treatment groups, the 0.7 mg/kg/day dosage group showed the most significant improvement.

EPILEPSY & BEHAVIOR (2023)

Review Clinical Neurology

Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper

Flavio Villani, Vittoria Cianci, Carlo Di Bonaventura, Giancarlo Di Gennaro, Carlo Andrea Galimberti, Renzo Guerrini, Angela La Neve, Oriano Mecarelli, Nicola Pietrafusa, Nicola Specchio, Federico Vigevano, Emilio Perucca

Summary: Cenobamate is a new antiseizure medication used to treat adults with focal-onset seizures. It has low adverse effects and can achieve significant clinical benefits at relatively low doses for many patients.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2023)

Article Immunology

Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience

Gabriele Monte, Laura Papetti, Michela Ada Noris Ferilli, Fabiana Ursitti, Romina Moavero, Giorgia Sforza, Elena Panella, Samuela Tarantino, Martina Proietti Checchi, Federico Vigevano, Paolo Palma, Massimiliano Valeriani

Summary: This study retrospectively evaluated the safety of SARS-CoV2 vaccination and the short-term outcome of COVID-19 in pediatric patients with acquired demyelinating disorders of the central nervous system. The results showed that most patients experienced mild side effects such as pain at the injection site, and there were no cases of disease relapse. Overall, the data supports the safety of SARS-CoV-2 vaccines in pediatric patients with multiple sclerosis, MOGAD, and NMOSD.

FRONTIERS IN IMMUNOLOGY (2023)

Article Medicine, General & Internal

Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series

Giovanni Falcicchio, Simona Lattanzi, Francesco Negri, Marina de Tommaso, Angela La Neve, Nicola Specchio

Summary: This retrospective study examined the 12-month effectiveness and tolerability of Cenobamate (CNB) in patients with Lennox-Gastaut syndrome (LGS) in real-world practice. The results showed a reduction in seizure frequency and minimal side effects after CNB treatment. These findings suggest that CNB may be a promising therapeutic option for drug-resistant epilepsy associated with LGS.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Neurosciences

Can Presurgical Interhemispheric EEG Connectivity Predict Outcome in Hemispheric Surgery? A Brain Machine Learning Approach

Chiara Pepi, Mattia Mercier, Giusy Carfi Pavia, Alessandro de Benedictis, Federico Vigevano, Maria Camilla Rossi-Espagnet, Giovanni Falcicchio, Carlo Efisio Marras, Nicola Specchio, Luca de Palma

Summary: This study used a brain machine learning approach to evaluate the role of inter-hemispheric EEG connectivity in predicting seizure outcome after hemispherotomy. The results showed that pre-surgical EEG features may have the potential to predict epilepsy outcome after hemispherotomy.

BRAIN SCIENCES (2023)

Article Neurosciences

Hemispherotomy in Infants with Hemimegalencephaly: Long-Term Seizure and Developmental Outcome in Early Treated Patients

Chiara Pepi, Alessandro De Benedictis, Maria Camilla Rossi-Espagnet, Simona Cappelletti, Martina Da Rold, Giovanni Falcicchio, Federico Vigevano, Carlo Efisio Marras, Nicola Specchio, Luca De Palma

Summary: Hemimegalencephaly (HME) is a rare brain congenital malformation that causes early onset drug-resistant epilepsy. Hemispherotomy is an effective treatment option for HME patients, but the long-term neuropsychological outcomes are variable.

BRAIN SCIENCES (2023)

Article Clinical Neurology

Phase-amplitude coupling between low- and high-frequency activities as preoperative biomarker of focal cortical dysplasia subtypes

Lorenzo Ricci, Eleonora Tamilia, Mattia Mercier, Chiara Pepi, Giusy Carfi-Pavia, Alessandro De Benedictis, Giovanni Assenza, Vincenzo Di Lazzaro, Federico Vigevano, Nicola Specchio, Luca de Palma

Summary: This study aimed to evaluate whether ictal phase-amplitude coupling (PAC) could be used as a preoperative biomarker for Focal Cortical Dysplasia (FCD) subtypes. It was found that the strength of ictal PAC was significantly higher in patients with FCD type II compared to type I, only on SOZ electrodes. Pre-ictal PAC on SOZ electrodes predicted FCD histopathology with a classification accuracy > 0.9.

CLINICAL NEUROPHYSIOLOGY (2023)

Article Clinical Neurology

WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk

Karen L. Oliver, Marina Trivisano, Simone A. Mandelstam, Angela De Dominicis, David I. Francis, Timothy E. Green, Alison M. Muir, Apoorva Chowdhary, Christoph Hertzberg, Klaus Goldhahn, Julia Metreau, Christine Prager, Jason Pinner, Michael Cardamone, Kenneth A. Myers, Richard J. Leventer, Gaetan Lesca, Melanie Bahlo, Michael S. Hildebrand, Heather C. Mefford, Angela M. Kaindl, Nicola Specchio, Ingrid E. Scheffer

Summary: This study analyzed the epileptology and imaging features of WWOX-DEE, and investigated genotype-phenotype correlations, particularly with regard to survival. The results showed that biallelic WWOX pathogenic variants cause an early infantile developmental and epileptic encephalopathy syndrome, with focal seizures and epileptic spasms being the most common seizure types. Patients with two null WWOX pathogenic variants have higher mortality risk.

EPILEPSIA (2023)

Article Pharmacology & Pharmacy

Cannabidiol use in patients with Dravet syndrome and Lennox-Gastaut syndrome: experts' opinions using a nominal group technique (NGT) approach

Paolo Bonanni, Francesca Ragona, Carlo Fusco, Antonio Gambardella, Francesca Felicia Operto, Lucio Parmeggiani, Stefano Sartori, Nicola Specchio

Summary: This study confirms that using pharmaceutical CBD is more reliable and safe than galenic formulations in patients with DS and LGS, based on expert opinions.

EXPERT OPINION ON PHARMACOTHERAPY (2023)

Article Neurosciences

Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic

Martina Proietti Checchi, Samuela Tarantino, Fabiana Ursitti, Gabriele Monte, Romina Moavero, Giorgia Sforza, Michela Ada Noris Ferilli, Teresa Grimaldi Capitello, Federico Vigevano, Massimiliano Valeriani, Laura Papetti

Summary: This study aimed to verify the variations in migraine course and psychological aspects in adolescent patients during different phases of the COVID-19 pandemic compared to the months before COVID-19. The results showed a significant increase in the frequency of attacks and use of prophylactic drugs during the second wave of the pandemic, as well as higher levels of anxiety and depression during both COVID periods compared to the pre-COVID months.

BRAIN SCIENCES (2023)

Article Clinical Neurology

A registry for Dravet syndrome: The Italian experience

Simona Balestrini, Viola Doccini, Sabrina Giometto, Ersilia Lucenteforte, Salvatore De Masi, Elisa Giarola, Isabella Brambilla, Federica Pieroni, Marco Perulli, Domenica Battaglia, Nicola Specchio, Francesca Ragona, Tiziana Granata, Simona Pellacani, Annarita Ferrari, Carla Marini, Sara Matricardi, Elisabetta Cesaroni, Lucio Giordano, Patrizia Accorsi, Vittorio Sciruicchio, Paolo Tinuper, Tullio Messana, Angelo Russo, Dario Pruna, Margherita Nosadini, Valentina De Giorgis, Davide Caputo, Serena Residras Collaboration Grp, Serena Pellegrin, Tommaso Lo Barco, Francesca Darra, Bernardo Dalla Bernardina, Renzo Guerrini

Summary: We present the Residras registry, a comprehensive resource for Dravet syndrome and other phenotypes related to SCN1A mutations. The registry collects standardized data from pediatric and adult patients in 24 Italian expert centers. The data includes demographic information, clinical outcomes, and mortality rates. The registry has currently enrolled 281 individuals with Dravet syndrome and a confirmed SCN1A mutation, and has observed changes in cognitive function, behavioral disorders, language, and intellectual disability over a 5-year follow-up period. The Residras registry provides valuable data for research, clinical trials, and monitoring the natural history of Dravet syndrome.

EPILEPSIA OPEN (2023)

暂无数据